WeTrials
Recruiting

A Phase 1 Study of 5-Fluorouracil in Combination With Abemaciclib in Metastatic, Refractory CRC

What is this study?

This early-stage study tests a combination of two cancer-fighting drugs, abemaciclib and 5-fluorouracil, for people with advanced colorectal cancer. Researchers want to find the safest and most effective dose to help stop tumor growth when standard treatments have stopped working.

Who can participate?

You may be able to join if you are 18 or older, have advanced colorectal cancer that has spread, and have previously tried standard treatments without success. Participants also need to be well enough to handle daily activities and meet basic health requirements.

What will happen?

During the study, you will receive the study medications and have regular check-ups, which include imaging scans like CT or MRI, blood tests, and sometimes small tissue samples. The medical team will monitor you closely to check for side effects and see how well the treatment is working.

Where and when?

This study is currently recruiting participants at locations in Irvine and Orange, California, as well as The Bronx, New York. If you live near these areas, your care team can help you figure out if travel is manageable.

Key Points
  • 1Tests a new drug combination for advanced colorectal cancer
  • 2Aims to find the best dose and check for safety
  • 3Currently looking for participants in California and New York

No related links yet

Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Metastatic Microsatellite Stable Colorectal CarcinomaRefractory Microsatellite Stable Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.